News Author: Susan London Publish date: December 7, 2018
SAN ANTONIO – A meta-analysis finds no added event-free survival benefit from adjuvant chemotherapy among the 21.1% of patients who achieved a pCR....
Video Author: Susan London Publish date: December 6, 2018
SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage b...
Video Author: Susan London Publish date: December 6, 2018
SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from subseque...
Video Author: Susan London Publish date: December 6, 2018
SAN ANTONIO – A phase 3 trial was unable to rule out the possibility that, after lumpectomy, partial breast irradiation is inferior to whole breast...
News Author: Susan London Publish date: December 6, 2018
SAN ANTONIO – A phase 3 trial was negative, showing that adding adjuvant capecitabine to surgery and chemotherapy does not improve survival in wome...
Article Author: Susan London Publish date: December 6, 2018
Video Author: Susan London Publish date: December 5, 2018
SAN ANTONIO – Adding adjuvant capecitabine to surgery and standard chemotherapy did not improve disease-free or overall survival in women with earl...
News Author: Susan London Publish date: December 1, 2018
A retrospective study suggests one in seven patients with newly diagnosed multiple myeloma (MM) who are eligible for transplant may live at least as l...
News Author: Susan London Publish date: November 29, 2018
A study has found that a sizable share of transplant-eligible patients can expect to live as long as similar people in the general population.
News Author: Susan London Publish date: November 7, 2018
SAN DIEGO – Improvements in heart failure functional class and quality of life after valve-in-valve TAVR are maintained out to at least 3 years.
News Author: Susan London Publish date: November 6, 2018
An Italian retrospective cohort study has found that tumor burden more consistently predicted survival than IMDC risk class and number of metastati...
News Author: Susan London Publish date: November 6, 2018
SAN DIEGO – The procedure reduced regurgitation to mild or moderate levels in nearly four-fifths of patients.
News Author: Susan London Publish date: November 5, 2018
San Diego – Two-year results of the BIOFLOW V randomized head-to-head comparison show superiority was driven by a lower rate of target vessel–relat...
News Author: Susan London Publish date: November 5, 2018
A retrospective cohort study of 294 patients with RCC finds that certain racial/ethnic minorities are younger at diagnosis and more often have adva...
News Author: Susan London Publish date: November 2, 2018
Patients whose clear cell or papillary RCC expresses high levels of KPNA2, a transport carrier protein, have an elevated risk of death.
